-
1
-
-
67649973722
-
The Importance of Drug-Target Residence Time
-
Zhang R., Monsma F.. The Importance of Drug-Target Residence Time. Curr. Opin. Drug Discov. Dev. 2009 ; 12: 488-496
-
(2009)
Curr. Opin. Drug Discov. Dev
, vol.12
, pp. 488-496
-
-
Zhang, R.1
Monsma, F.2
-
2
-
-
77958535230
-
Binding Kinetics and Mechanism of Action: Toward the Discovery and Development of Better and Best in Class Drugs
-
Zhang R., Monsma F.. Binding Kinetics and Mechanism of Action: Toward the Discovery and Development of Better and Best in Class Drugs. Expert Opin. Drug Discov. 2010 ; 5: 1023-1029
-
(2010)
Expert Opin. Drug Discov
, vol.5
, pp. 1023-1029
-
-
Zhang, R.1
Monsma, F.2
-
3
-
-
4544381198
-
Biochemical mechanisms of drug action: What does it take for success?
-
DOI 10.1038/nrd1500
-
Swinney D. C.. Biochemical Mechanisms of Drug Action: What Does It Take for Success?. Nat. Rev. Drug Discov. 2004 ; 3: 801-808 (Pubitemid 39242832)
-
(2004)
Nature Reviews Drug Discovery
, vol.3
, Issue.9
, pp. 801-808
-
-
Swinney, D.C.1
-
4
-
-
33748325882
-
Drug-target residence time and its implications for lead optimization
-
DOI 10.1038/nrd2082, PII NRD2082
-
Copeland R. A., Pompliano D. L., Meek T. D.. Drug-Target Residence Time and Its Implications for Lead Optimization. Nat. Rev. Drug Discov. 2006 ; 5: 730-739 (Pubitemid 44323700)
-
(2006)
Nature Reviews Drug Discovery
, vol.5
, Issue.9
, pp. 730-739
-
-
Copeland, R.A.1
Pompliano, D.L.2
Meek, T.D.3
-
5
-
-
0037047697
-
Biochemical Characterization of Desloratadine, a Potent Antagonist of the Human Histamine H1 Receptor
-
Anthes J. C., Gilchrest H., Richard C., Eckel S., Hesk D., West R. E., Williams S. M., Greenfeder S., Billah M., Kreutner W., et al. Biochemical Characterization of Desloratadine, a Potent Antagonist of the Human Histamine H1 Receptor. Eur. J. Pharmacol. 2002 ; 449: 229-237
-
(2002)
Eur. J. Pharmacol
, vol.449
, pp. 229-237
-
-
Anthes, J.C.1
Gilchrest, H.2
Richard, C.3
Eckel, S.4
Hesk, D.5
West, R.E.6
Williams, S.M.7
Greenfeder, S.8
Billah, M.9
Kreutner, W.10
-
6
-
-
33644796110
-
Evaluation of Enzyme Inhibitors in Drug Discovery: A Guide for Medicinal Chemists and Pharmacologists
-
Copeland R. A.. Evaluation of Enzyme Inhibitors in Drug Discovery: A Guide for Medicinal Chemists and Pharmacologists. Methods Biochem. Anal. 2005 ; 46: 1-265
-
(2005)
Methods Biochem. Anal
, vol.46
, pp. 1-265
-
-
Copeland, R.A.1
-
7
-
-
0031566881
-
1 receptor
-
DOI 10.1016/S0014-2999(96)00837-0, PII S0014299996008370
-
Ojima M., Inada Y., Shibouta Y., Wada T., Sanada T., Kubo K., Nishikawa K.. Candesartan (CV-11974) Dissociates Slowly from the Angiotensin AT1 Receptor. Eur. J. Pharmacol. 1997 ; 319: 137-146 (Pubitemid 27051327)
-
(1997)
European Journal of Pharmacology
, vol.319
, Issue.1
, pp. 137-146
-
-
Ojima, M.1
Inada, Y.2
Shibouta, Y.3
Wada, T.4
Sanada, T.5
Kubo, K.6
Nishikawa, K.7
-
8
-
-
79956212667
-
Functional and Biochemical Rationales for the 24-Hour Long Duration of Action of Olodaterol
-
Casarosa P., Kollak I., Kiechle T., Ostermann A., Schnapp A., Kiesling R., Pieper M., Sieger P., Gantner F.. Functional and Biochemical Rationales for the 24-Hour Long Duration of Action of Olodaterol. J. Pharmacol. Exp. Ther. 2011 ; 337: 600-609
-
(2011)
J. Pharmacol. Exp. Ther
, vol.337
, pp. 600-609
-
-
Casarosa, P.1
Kollak, I.2
Kiechle, T.3
Ostermann, A.4
Schnapp, A.5
Kiesling, R.6
Pieper, M.7
Sieger, P.8
Gantner, F.9
-
9
-
-
33749358578
-
3 receptor
-
DOI 10.1038/sj.bjp.0706819, PII 0706819
-
Dowling M. R., Charlton S. J.. Quantifying the Association and Dissociation Rates of Unlabelled Antagonists at the Muscarinic M3 Receptor. Br. J. Pharmacol. 2006 ; 148: 927-937 (Pubitemid 44543610)
-
(2006)
British Journal of Pharmacology
, vol.148
, Issue.7
, pp. 927-937
-
-
Dowling, M.R.1
Charlton, S.J.2
-
10
-
-
77956840539
-
Estimation of the Dissociation Rate of Unlabelled Ligand-Receptor Complexes by a 'Two-Step' Competition Binding Approach
-
Packeu A., Wennerberg M., Balendran A., Vauquelin G.. Estimation of the Dissociation Rate of Unlabelled Ligand-Receptor Complexes by a 'Two-Step' Competition Binding Approach. Br. J. Pharmacol. 2010 ; 161: 1311-1328
-
(2010)
Br. J. Pharmacol
, vol.161
, pp. 1311-1328
-
-
Packeu, A.1
Wennerberg, M.2
Balendran, A.3
Vauquelin, G.4
-
11
-
-
0021336303
-
The kinetics of competitive radioligand binding predicted by the law of mass action
-
Motulsky H. J., Mahan L. C.. The Kinetics of Competitive Radioligand Binding Predicted by the Law of Mass Action. Mol. Pharmacol. 1984 ; 25: 1-9 (Pubitemid 14223246)
-
(1984)
Molecular Pharmacology
, vol.25
, Issue.1
, pp. 1-9
-
-
Motulsky, H.J.1
Mahan, L.C.2
-
12
-
-
0035209620
-
International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors
-
Fredholm B. B., IJzerman A. P., Jacobson K. A., Klotz K. N., Linden J.. International Union of Pharmacology, XXV: Nomenclature and Classification of Adenosine Receptors. Pharmacol. Rev. 2001 ; 53: 527-552 (Pubitemid 33136237)
-
(2001)
Pharmacological Reviews
, vol.53
, Issue.4
, pp. 527-552
-
-
Fredholm, B.B.1
Ijzerman, A.P.2
Jacobson, K.A.3
Klotz, K.-N.4
Linden, J.5
-
13
-
-
79952033865
-
International Union of Basic and Clinical Pharmacology, LXXXI: Nomenclature and Classification of Adenosine Receptors - An Update
-
Fredholm B. B., IJzerman A. P., Jacobson K. A., Linden J., Müller C. E.. International Union of Basic and Clinical Pharmacology, LXXXI: Nomenclature and Classification of Adenosine Receptors - An Update. Pharmacol. Rev. 2011 ; 63: 1-34
-
(2011)
Pharmacol. Rev
, vol.63
, pp. 1-34
-
-
Fredholm, B.B.1
Ijzerman, A.P.2
Jacobson, K.A.3
Linden, J.4
Müller, C.E.5
-
14
-
-
33644770260
-
Adenosine receptors as therapeutic targets
-
DOI 10.1038/nrd1983, PII N1983
-
Jacobson K. A., Gao Z. G.. Adenosine Receptors as Therapeutic Targets. Nat. Rev. Drug Discov. 2006 ; 5: 247-264 (Pubitemid 43336037)
-
(2006)
Nature Reviews Drug Discovery
, vol.5
, Issue.3
, pp. 247-264
-
-
Jacobson, K.A.1
Gao, Z.-G.2
-
15
-
-
34748836955
-
Emerging adenosine receptor agonists
-
DOI 10.1517/14728214.12.3.479
-
Gao Z. G., Jacobson K. A.. Emerging Adenosine Receptor Agonists. Expert Opin. Emerg. Drugs. 2007 ; 12: 479-492 (Pubitemid 47518380)
-
(2007)
Expert Opinion on Emerging Drugs
, vol.12
, Issue.3
, pp. 479-492
-
-
Gao, Z.-G.1
Jacobson, K.A.2
-
16
-
-
0035953021
-
1 antagonist, as a 'receptor knock-down' tool
-
DOI 10.1016/S0960-894X(01)00069-5, PII S0960894X01000695
-
Van Muijlwijk-Koezen J. E., Timmerman H., Van der Sluis R. P., Van de Stolpe A. C., Menge W. M., Beukers M. W., Van der Graaf P. H., De Groote M., IJzerman A. P.. Synthesis and Use of FSCPX, an Irreversible Adenosine A1 Antagonist, as a 'Receptor Knock-Down' Tool. Bioorg. Med. Chem. Lett. 2001 ; 11: 815-818 (Pubitemid 32230687)
-
(2001)
Bioorganic and Medicinal Chemistry Letters
, vol.11
, Issue.6
, pp. 815-818
-
-
Van Muijlwijk-Koezen, J.E.1
Timmerman, H.2
Van Der Sluis, R.P.3
Van De Stolpe, A.C.4
Menge, W.M.P.B.5
Beukers, M.W.6
Van Der Graaf, P.H.7
De Groote, M.8
Ijzerman, A.P.9
-
17
-
-
33646737062
-
2,6-Disubstituted and 2,6,8-Trisubstituted Purines as Adenosine Receptor Antagonists
-
Chang L. C., Spanjersberg R. F., Von Frijtag Drabbe Kunzel J. K., Mulder-Krieger T., Brussee J., IJzerman A. P.. 2,6-Disubstituted and 2,6,8-Trisubstituted Purines as Adenosine Receptor Antagonists. J. Med. Chem. 2006 ; 49: 2861-2867
-
(2006)
J. Med. Chem
, vol.49
, pp. 2861-2867
-
-
Chang, L.C.1
Spanjersberg, R.F.2
Von Frijtag Drabbe Kunzel, J.K.3
Mulder-Krieger, T.4
Brussee, J.5
Ijzerman, A.P.6
-
18
-
-
40949094828
-
A new generation of adenosine receptor antagonists: From di- to trisubstituted aminopyrimidines
-
DOI 10.1016/j.bmc.2008.01.013, PII S096808960800014X
-
Van Veldhoven J. P., Chang L. C., von Frijtag Drabbe Kunzel J. K., Mulder-Krieger T., Struensee-Link R., Beukers M. W., Brussee J., IJzerman A. P.. A New Generation of Adenosine Receptor Antagonists: From Di- to Trisubstituted Aminopyrimidines. Bioorg. Med. Chem. 2008 ; 16: 2741-2752 (Pubitemid 351418225)
-
(2008)
Bioorganic and Medicinal Chemistry
, vol.16
, Issue.6
, pp. 2741-2752
-
-
Van Veldhoven, J.P.D.1
Chang, L.C.W.2
Von Frijtag Drabbe Kunzel, J.K.3
Mulder-Krieger, T.4
Struensee-Link, R.5
Beukers, M.W.6
Brussee, J.7
Ijzerman, A.P.8
-
19
-
-
0023113567
-
1 receptor subtype
-
Martinson E. A., Johnson R. A., Wells J. N.. Potent Adenosine Receptor Antagonists That Are Selective for the A1 Receptor Subtype. Mol. Pharmacol. 1987 ; 31: 247-252 (Pubitemid 17048690)
-
(1987)
Molecular Pharmacology
, vol.31
, Issue.3
, pp. 247-252
-
-
Martinson, E.A.1
Johnson, R.A.2
Wells, J.N.3
-
20
-
-
33644831847
-
1 receptors of LUF5831, a novel nonadenosine-like agonist
-
DOI 10.1038/sj.bjp.0706655, PII 0706655
-
Heitman L. H., Mulder-Krieger T., Spanjersberg R. F., von Frijtag Drabbe Kunzel J. K., Dalpiaz A., IJzerman A. P.. Allosteric Modulation, Thermodynamics and Binding to Wild-Type and Mutant (T277A) Adenosine A1 Receptors of LUF5831, a Novel Nonadenosine-Like Agonist. Br. J. Pharmacol. 2006 ; 147: 533-541 (Pubitemid 43355051)
-
(2006)
British Journal of Pharmacology
, vol.147
, Issue.5
, pp. 533-541
-
-
Heitman, L.H.1
Mulder-Krieger, T.2
Spanjersberg, R.F.3
Von Frijtag Drabbe Kunzel, J.K.4
Dalpiaz, A.5
Ijzerman, A.P.6
-
21
-
-
0022186670
-
Measurement of protein using bicinchoninic acid
-
DOI 10.1016/0003-2697(85)90442-7
-
Smith P. K., Krohn R. I., Hermanson G. T., Mallia A. K., Gartner F. H., Provenzano M. D., Fujimoto E. K., Goeke N. M., Olson B. J., Klenk D. C.. Measurement of Protein Using Bicinchoninic Acid. Anal. Biochem. 1985 ; 150: 76-85 (Pubitemid 16258399)
-
(1985)
Analytical Biochemistry
, vol.150
, Issue.1
, pp. 76-85
-
-
Smith, P.K.1
Krohn, R.I.2
Hermanson, G.T.3
-
22
-
-
0022653208
-
Evaluation of the binding of the A-1 selective adenosine radioligand, cyclopentyladenosine (CPA), to rat brain tissue
-
Williams M., Braunwalder A., Erickson T. J.. Evaluation of the Binding of the A1 Selective Adenosine Radioligand, Cyclopentyladenosine (CPA), to Rat Brain Tissue. N-S Arch. Pharmacol. 1986 ; 332: 179-183 (Pubitemid 16134507)
-
(1986)
Naunyn-Schmiedeberg's Archives of Pharmacology
, vol.332
, Issue.2
, pp. 179-183
-
-
Williams, M.1
Braunwalder, A.2
Erickson, T.J.3
-
23
-
-
0015861774
-
Relationship between the Inhibition Constant (K1) and the Concentration of Inhibitor which Causes 50 Percent Inhibition (I50) of an Enzymatic Reaction
-
Cheng Y., Prusoff W. H.. Relationship between the Inhibition Constant (K1) and the Concentration of Inhibitor which Causes 50 Percent Inhibition (I50) of an Enzymatic Reaction. Biochem. Pharmacol. 1973 ; 22: 3099-3108
-
(1973)
Biochem. Pharmacol
, vol.22
, pp. 3099-3108
-
-
Cheng, Y.1
Prusoff, W.H.2
-
24
-
-
80054968429
-
Pharmacological Characterization of GSK1004723, a Novel, Long-Acting Antagonist at Histamine H1 and H3 Receptors
-
Slack R. J., Russell L. J., Hall D. A., Luttmann M. A., Ford A. J., Saunders K. A., Hodgson S. T., Connor H. E., Browning C., Clark K. L.. Pharmacological Characterization of GSK1004723, a Novel, Long-Acting Antagonist at Histamine H1 and H3 Receptors. Br. J. Pharmacol. 2011 ; 164: 1627-1641
-
(2011)
Br. J. Pharmacol
, vol.164
, pp. 1627-1641
-
-
Slack, R.J.1
Russell, L.J.2
Hall, D.A.3
Luttmann, M.A.4
Ford, A.J.5
Saunders, K.A.6
Hodgson, S.T.7
Connor, H.E.8
Browning, C.9
Clark, K.L.10
-
25
-
-
33847667536
-
Scintillation proximity assay as a high-throughput method to identify slowly dissociating nonpeptide ligand binding to the GnRH receptor
-
DOI 10.1177/1087057106297362
-
Heise C. E., Sullivan S. K., Crowe P. D.. Scintillation Proximity Assay as a High-Throughput Method to Identify Slowly Dissociating Nonpeptide Ligand Binding to the GnRH Receptor. J. Biomol. Screen. 2007 ; 12: 235-239 (Pubitemid 46364424)
-
(2007)
Journal of Biomolecular Screening
, vol.12
, Issue.2
, pp. 235-239
-
-
Heise, C.E.1
Sullivan, S.K.2
Crowe, P.D.3
-
26
-
-
77957577496
-
Fused Tricyclic Pyrrolizinones That Exhibit Pseudo-Irreversible Blockade of the NK1 Receptor
-
Morriello G. J., Chicchi G., Johnson T., Mills S. G., Demartino J., Kurtz M., Tsao K. L., Zheng S., Tong X., Carlson E., et al. Fused Tricyclic Pyrrolizinones That Exhibit Pseudo-Irreversible Blockade of the NK1 Receptor. Bioorg. Med. Chem. Lett. 2010 ; 20: 5925-5932
-
(2010)
Bioorg. Med. Chem. Lett
, vol.20
, pp. 5925-5932
-
-
Morriello, G.J.1
Chicchi, G.2
Johnson, T.3
Mills, S.G.4
Demartino, J.5
Kurtz, M.6
Tsao, K.L.7
Zheng, S.8
Tong, X.9
Carlson, E.10
-
27
-
-
0033797928
-
Comparative Pharmacodynamics and Pharmacokinetics of Candesartan and Losartan in Man
-
Fuchs B., Breithaupt-Grogler K., Belz G. G., Roll S., Malerczyk C., Herrmann V., Spahn-Langguth H., Mutschler E.. Comparative Pharmacodynamics and Pharmacokinetics of Candesartan and Losartan in Man. J. Pharm. Pharmacol 5. 2000 ; 2: 1075-1083
-
(2000)
J. Pharm. Pharmacol 5
, vol.2
, pp. 1075-1083
-
-
Fuchs, B.1
Breithaupt-Grogler, K.2
Belz, G.G.3
Roll, S.4
Malerczyk, C.5
Herrmann, V.6
Spahn-Langguth, H.7
Mutschler, E.8
-
28
-
-
84855840733
-
Target-Drug Interactions: First Principles and Their Application to Drug Discovery
-
Nunez S., Venhorst J., Kruse C. G.. Target-Drug Interactions: First Principles and Their Application to Drug Discovery. Drug Discov. Today. 2012 ; 17: 10-22
-
(2012)
Drug Discov. Today
, vol.17
, pp. 10-22
-
-
Nunez, S.1
Venhorst, J.2
Kruse, C.G.3
-
29
-
-
0035370715
-
2 receptor [multiple letter]
-
DOI 10.1016/S0006-3223(01)01110-6, PII S0006322301011106
-
Kapur S., Seeman P.. Ketamine Has Equal Affinity for NMDA Receptors and the High-Affinity State of the Dopamine D2 Receptor. Biol. Psychiatry. 2001 ; 49: 954-957 (Pubitemid 32493818)
-
(2001)
Biological Psychiatry
, vol.49
, Issue.11
, pp. 954-957
-
-
Kapur, S.1
Seeman, P.2
-
30
-
-
33644922637
-
Efficacy and Adverse Effects of Atypical Antipsychotics for Dementia: Meta-Analysis of Randomized, Placebo-Controlled Trials
-
Schneider L. S., Dagerman K., Insel P. S.. Efficacy and Adverse Effects of Atypical Antipsychotics for Dementia: Meta-Analysis of Randomized, Placebo-Controlled Trials. Am. J. Geriatr. Psychiatry. 2006 ; 14: 191-210
-
(2006)
Am. J. Geriatr. Psychiatry
, vol.14
, pp. 191-210
-
-
Schneider, L.S.1
Dagerman, K.2
Insel, P.S.3
-
31
-
-
80052569232
-
Quantitative Pharmacological Analysis of Antagonist Binding Kinetics at CRF1 Receptors in Vitro and in Vivo
-
Ramsey S. J., Attkins N. J., Fish R., van der Graaf P. H.. Quantitative Pharmacological Analysis of Antagonist Binding Kinetics at CRF1 Receptors In Vitro and In Vivo. Br. J. Pharmacol. 2011 ; 164: 992-1007
-
(2011)
Br. J. Pharmacol
, vol.164
, pp. 992-1007
-
-
Ramsey, S.J.1
Attkins, N.J.2
Fish, R.3
Van Der Graaf, P.H.4
-
32
-
-
84863228021
-
Functional Efficacy of Adenosine A2A Receptor Agonists Is Positively Correlated to Their Receptor Residence Time
-
Guo D., Mulder-Krieger T., IJzerman A. P., Heitman L. H.. Functional Efficacy of Adenosine A2A Receptor Agonists Is Positively Correlated to Their Receptor Residence Time. Br. J. Pharmacol. 2012 ; 166: 1846-1859
-
(2012)
Br. J. Pharmacol
, vol.166
, pp. 1846-1859
-
-
Guo, D.1
Mulder-Krieger, T.2
Ijzerman, A.P.3
Heitman, L.H.4
|